Search research articles
Contact Us
Filters
Showing results (161-170 of 174) with videos related to
Page
of 18
Sort By:
Molecular Cancer Therapeutics
|
July 2, 2014
Translational exposure-efficacy modeling to optimize the dose and schedule of taxanes combined with the investigational Aurora A kinase inhibitor MLN8237 (alisertib)
Jessica J Huck, Mengkun Zhang, Jerome Mettetal, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology
|
December 19, 2008
Contrast echocardiography for pulmonary arteriovenous malformations screening: does any bubble matter?
P Gazzaniga, E Buscarini, G Leandro, et al.
Toxicologic Pathology
|
April 23, 2016
Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy
Michael E Dunn, Thomas G Manfredi, Kevin Agostinucci, et al.
Oncogene
|
April 4, 2017
Selected mitochondrial DNA landscapes activate the SIRT3 axis of the UPR<sup>mt</sup> to promote metastasis
T C Kenny, P Hart, M Ragazzi, et al.
Molecular Cancer Therapeutics
|
May 22, 2012
MLN0905, a small-molecule plk1 inhibitor, induces antitumor responses in human models of diffuse large B-cell lymphoma
Judy Quiju Shi, Kerri Lasky, Vaishali Shinde, et al.
Nature Communications
|
August 13, 2020
Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine
Luis Felipe Campesato, Sadna Budhu, Jeremy Tchaicha, et al.
Nature Communications
|
June 27, 2022
Light-induced charge generation in polymeric nanoparticles restores vision in advanced-stage retinitis pigmentosa rats
S Francia, D Shmal, S Di Marco, et al.
Orphanet Journal of Rare Diseases
|
August 30, 2019
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia
C L Shovlin, C M Millar, F Droege, et al.
ACS Medicinal Chemistry Letters
|
June 24, 2015
MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors
Todd B Sells, Ryan Chau, Jeffrey A Ecsedy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2011
Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of aurora A kinase using novel in vivo pharmacodynamic assays
Mark G Manfredi, Jeffrey A Ecsedy, Arijit Chakravarty, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 174) with videos related to
Sort By:
Page
of 18
Molecular Cancer Therapeutics
|
July 2, 2014
Translational exposure-efficacy modeling to optimize the dose and schedule of taxanes combined with the investigational Aurora A kinase inhibitor MLN8237 (alisertib)
Jessica J Huck, Mengkun Zhang, Jerome Mettetal, et al.
European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology
|
December 19, 2008
Contrast echocardiography for pulmonary arteriovenous malformations screening: does any bubble matter?
P Gazzaniga, E Buscarini, G Leandro, et al.
Toxicologic Pathology
|
April 23, 2016
Serum Natriuretic Peptides as Differential Biomarkers Allowing for the Distinction between Physiologic and Pathologic Left Ventricular Hypertrophy
Michael E Dunn, Thomas G Manfredi, Kevin Agostinucci, et al.
Oncogene
|
April 4, 2017
Selected mitochondrial DNA landscapes activate the SIRT3 axis of the UPR<sup>mt</sup> to promote metastasis
T C Kenny, P Hart, M Ragazzi, et al.
Molecular Cancer Therapeutics
|
May 22, 2012
MLN0905, a small-molecule plk1 inhibitor, induces antitumor responses in human models of diffuse large B-cell lymphoma
Judy Quiju Shi, Kerri Lasky, Vaishali Shinde, et al.
Nature Communications
|
August 13, 2020
Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine
Luis Felipe Campesato, Sadna Budhu, Jeremy Tchaicha, et al.
Nature Communications
|
June 27, 2022
Light-induced charge generation in polymeric nanoparticles restores vision in advanced-stage retinitis pigmentosa rats
S Francia, D Shmal, S Di Marco, et al.
Orphanet Journal of Rare Diseases
|
August 30, 2019
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia
C L Shovlin, C M Millar, F Droege, et al.
ACS Medicinal Chemistry Letters
|
June 24, 2015
MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors
Todd B Sells, Ryan Chau, Jeffrey A Ecsedy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 22, 2011
Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of aurora A kinase using novel in vivo pharmacodynamic assays
Mark G Manfredi, Jeffrey A Ecsedy, Arijit Chakravarty, et al.
Page
of 18